March 15, 2006
Clinical Trials And Tribulations
MaFtFrom Drug Company TeGenero‘s website: “TGN1412 is a promising novel approach to addressing the medical need in … inflammatory diseases, which require long-term therapy without severe side effects.” I think they may have found one side-effect though… quite severe too! My thoughts go out to those involved – and remember kids, there’s no such thing as easy money! Shoetree, you have been warned! MaFt **********http://maft.co.uk/blog